The Value of Online CME in the Multidisciplinary Care of Patients with NTRK Fusion-Positive Thyroid Cancer

被引：0
|
作者：
Worst, M. A. [1 ]
Carothers, A. [1 ]
Surducan, M. [1 ]
Sipos, J. [2 ]
Wirth, L. [3 ]
机构：
[1] Medscape LLC, New York, NY USA
[2] Arthur G James Comprehens Canc Ctr, Columbus, OH USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 112卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
187
引用
收藏
页码：E50 / E51
页数：2
相关论文
共 50 条
  • [41] Characteristics and outcomes of patients (pts) with NTRK fusion-positive (NTRK plus ) metastatic/locally advanced (LA) solid tumours receiving non-TRK inhibitor (TRKi) standard of care (SoC), and prognostic value of NTRK fusions in clinical practice
    Demetri, G. D.
    Peters, S.
    Hibbar, D. P.
    Davies, J.
    Maund, S. L.
    Veronese, L.
    Liu, H.
    Humblet, O.
    Perez, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S399 - S399
  • [42] TRK INHIBITOR TREATMENT PATTERNS IN PATIENTS WITH NTRK FUSION-POSITIVE SOLID TUMORS: A MULTISITE COHORT STUDY AT US ACADEMIC CANCER CENTERS
    Willis, C.
    Au, T.
    Griswold, C.
    Schabath, M. B.
    Thompson, J.
    Malhotra, J.
    Ko, G.
    Appukkuttan, S.
    Warnock, N.
    Kong, S.
    Hocum, B.
    Brixner, D.
    Stenehjem, D.
    VALUE IN HEALTH, 2022, 25 (12) : S41 - S41
  • [43] Complete Response on Larotrectinib in NTRK2 Fusion-Positive Non-Small Cell Lung Cancer
    Frehner, Lorenz
    Haefliger, Simon
    Cerciello, Ferdinando
    Grob, Tobias
    Schmid, Sabine
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 871 - 877
  • [44] Clinical characteristics and treatment patterns of patients with NTRK fusion-positive solid tumors: A multisite cohort study at US academic cancer centers
    Willis, Connor
    Au, Trang
    Hejazi, Andre
    Griswold, Cassia
    Schabath, Matthew B.
    Thompson, Jonathan
    Malhotra, Jyoti
    Federman, Noah
    Ko, Gilbert
    Appukkuttan, Sreevalsa
    Warnock, Neil
    Kong, Sheldon X.
    Hocum, Brian
    Brixner, Diana
    Stenehjem, David
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (07): : 672 - 683
  • [45] How selecting best therapy for metastatic NTRK fusion-positive non-small cell lung cancer?
    Ekman, Simon
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (06) : 2535 - 2544
  • [46] Clinicopathologic Spectrum of NTRK fusion-positive Tumors Detected by Clinical RNA Sequencing Panel
    Garcia, Annie
    Reuther, Jacquelyn
    Voicu, Horatiu
    Mohila, Carrie
    Adesina, Adekunle
    Schady, Deborah
    Wang, Wei-Lien
    Lazar, Alexander
    Lopez-Terrada, Dolores
    Lin, Frank
    Venkatramani, Rajkumar
    Plon, Sharon
    Parsons, Williams
    Fisher, Kevin
    Roy, Angshumoy
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 36 - 37
  • [47] Efficacy and Safety of Larotrectinib in Pediatric Patients with NTRK Fusion-Positive Primary Central Nervous System (CNS) Tumors
    Goto, Hiroaki
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [48] ADJUVANT LAROTRECTINIB THERAPY IN TWO CHILDREN WITH POOR PROGNOSIS NTRK FUSION-POSITIVE CANCERS
    Febres, Maria Carter
    Schneller, Netta
    Fair, Douglas
    Putnam, Angelica
    Linscott, Luke
    Bruggers, Carol
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S129 - S130
  • [49] Sequential treatments with TRK inhibitors in a patient with NTRK fusion-positive sarcoma: A case report
    Kubota, Yuta
    Kawano, Masanori
    Iwasaki, Tatsuya
    Itonaga, Ichiro
    Tsumura, Hiroshi
    Kaku, Nobuhiro
    Tanaka, Kazuhiro
    MEDICINE, 2023, 102 (49) : E36232
  • [50] Clinicopathologic Spectrum of NTRK fusion-positive Tumors Detected by Clinical RNA Sequencing Panel
    Garcia, Annie
    Reuther, Jacquelyn
    Voicu, Horatiu
    Mohila, Carrie
    Adesina, Adekunle
    Schady, Deborah
    Wang, Wei-Lien Billy
    Lazar, Alexander
    Lopez-Terrada, Dolores
    Lin, Frank
    Venkatramani, Rajkumar
    Plon, Sharon
    Parsons, Williams
    Fisher, Kevin
    Roy, Angshumoy
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 36 - 37
12345